The biotechnology services provider expanded its offerings with advanced gene expression analysis technology for research ...
Advances in 3D spatial multiomics are changing how researchers study tissue architecture. We spoke with Stellaromics' CEO, Dr. Todd Dickinson, to learn how this approach preserves structure and ...
SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- OmicInsight Corporation, an innovator in ...
A new software tool, ovrlpy, improves quality control in spatial transcriptomics, a key technology in biomedical research. Developed by the Berlin Institute of Health at Charité (BIH) in international ...
Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ Spatial Transcriptomics services are now ...
What do healthy bone marrow cells in children look like? For the first time, researchers have mapped this out. Scientists at the Princess Máxima Center examined nearly 91,000 individual bone marrow ...
The global spatial biology market is projected to grow at a compound annual growth rate (CAGR) of approximately 15% over the ...
The market is fueled by the technology’s ability to map biomolecules and cellular interactions within tissues, enabling ...
News-Medical.Net on MSN
New spatial omics platform advances biomedical research in Spain
Spatial omics is a new generation of technologies that allow scientists to study cells in their original location within ...
Researchers launched external beta testing of a 3D spatial transcriptomics system that maps intact tumors in three dimensions and enabling single-cell resolution.
The new software tool ovrlpy improves quality control in spatial transcriptomics, a key technology in biomedical research. Developed by the Berlin Institute of Health at Charité (BIH) in international ...
11hon MSN
A single sample classifier can predict cancer-associated fibroblast subtypes in patient samples
In a collaboration between several labs at UNC Lineberger, researchers have defined cancer-associated fibroblast (CAF) subtypes that are clinically robust, prognostic, and predictive of immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results